Architect Therapeutics

C-H activation to design and synthesize novel 3D scaffolds

Architect Therapeutics was founded in 2023, is headquartered in San Diego, United States, lists 11–50 employees, and has $120.0M in recorded funding across 3 rounds.

Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$120.0M
Last Round
Series BJan 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Architect Therapeutics is a San Diego biopharmaceutical company leveraging C-H bond activation chemistry pioneered by founder Jin-Quan Yu to design novel 3D small molecule drug architectures. The platform integrates covalent and non-covalent drug discovery approaches with proprietary libraries and advanced screening to pursue first- and best-in-class therapies in immunology and oncology.

Summary

Architect Therapeutics is a Biotech company based in San Diego, United States, founded in 2023. It lists 11–50 employees. It has raised $120.0M in total across 3 rounds, most recently a Series B round in Jan 2024. Investors include OrbiMed, ARCH Venture Partners and Frazier Healthcare.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries B2024 (est.)

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Architect Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/architect-therapeutics"><img src="https://indexed.vc/api/badge/company/architect-therapeutics" alt="Architect Therapeutics on Indexed.vc" width="260" height="76" /></a>